Podbit · TED Talks Daily
GLP-1s don't just reduce appetite — they appear to dampen dopamine spikes across every major addiction: alcohol, cocaine, nicotine, gambling, even social media. A neuroscientist told Khullar this suggests addiction has a single universal pathology, and GLP-1s may be part of how we fix it.
Where this was said
At 8:30 · chapter starts 5:29
The centerpiece of the episode, Khullar's TED Talk opens with Mary — a patient who had failed rehab, AA, and Antabuse before enrolling in an Ozempic clinical trial and achieving sobriety [1] — Dhruv Khullar "Mary had tried rehab, AA, and Antabuse — and failed every time. Then she enrolled in a clinical trial for Ozempic. Within weeks, the cravin…" 05:29 . From there, Khullar unfolds the drug's origin story: discovered in the 1980s but unworkable until a Gila monster researcher found a peptide in lizard venom that lasted hours rather than minutes. That discovery unlocked a class of drugs now showing effects far beyond digestion — specifically in the brain's mesolimbic reward pathway. GLP-1s appear to blunt dopamine spikes across every major addiction: alcohol, cocaine, nicotine, gambling, even social media. One neuroscientist told Khullar this suggests addiction may have a single universal pathology. But Khullar urges caution: these 'moderation molecules' can become desire dampeners, and anhedonia is a real risk. He closes by invoking Aristotle — and then dismantling him: Aristotle never faced Doritos, TikTok, or fentanyl. Moderation today isn't just a virtue; it is, the science suggests, a physiological state [2] — Dhruv Khullar "GLP-1s suggest that Aristotle's moderation, it's not just a virtue, it is a physiological state. It isn't just about character, it is about…" 14:44 .
Mary had tried rehab, AA, and Antabuse — and failed every time. Then she enrolled in a clinical trial for Ozempic. Within weeks, the craving was gone. She stopped drinking, lost 55 pounds, ended a bad relationship, and started exercising. GLP-1s didn't just treat her addiction; they gave her room to rebuild her life.
GLP-1 was discovered in the 1980s, but it broke down in minutes — useless as a drug. The breakthrough came from an unexpected place: Gila monster venom, which contained a similar peptide that could persist for hours. That discovery launched one of the most consequential drug classes in modern medicine.
GLP-1 (glucagon-like peptide 1) was first discovered in the 1980s and initially studied for diabetes management.
A scientist studying Gila monsters discovered the lizard's venom contained a GLP-1-like peptide that could persist for hours, catalyzing the GLP-1 drug revolution.
GLP-1s blunt the dopamine spikes triggered by cocaine, alcohol, and other addictive substances — but they don't drain dopamine entirely. Mice given GLP-1s and cocaine had smaller dopamine surges but maintained baseline neurotransmitter levels. The drugs moderate without eliminating the will to live.
Predictions that AI would eliminate radiologists were spectacularly wrong. Since those predictions, Mayo Clinic's radiology staff grew 55% and the specialty became the second-highest paid in medicine. The reason: AI automated scan-reading, but only 36% of a radiologist's time was ever spent doing that.
Self-help fails because people are sold one universal cure by the hyper-responders who had a transformative result from it. The real problem is context: every method works for the right person at the right time, which is almost never you just because the author says so.
Spencer Greenberg was once so socially anxious his heart pounded just approaching a stranger. His therapist gave him homework: go to a bar alone, talk to 5 strangers. Starting with asking for the time, he worked up to asking men for hugs — and his anxiety fell dramatically in 6 months.
A person who flies regularly but obsessively checks weather forecasts before every flight is not doing exposure therapy — they're teaching their brain that flying is only safe with the ritual. Safety behaviors prevent the brain from ever learning that the feared thing is actually fine.
The worry-time technique assigns all worries to one scheduled slot (e.g. 5 PM). Every time a worry surfaces, you write it down and ban yourself from engaging with it until that time. When 5 PM arrives, most worries feel trivial and the act of batch-worrying exposes how little it actually accomplishes.
In a randomized study of 20 habit techniques, 'habit reflection' stood out: recall a past habit you successfully built, write down what helped you succeed, then apply those same strategies to your new habit. It works because it's self-adapting — it uses whatever worked for YOU.
The tiny habits technique — always having a minimal version of your habit you can do when life gets in the way — keeps the mental machinery of habit formation from breaking. Paradoxically, people given a tiny-habit fallback option were MORE successful at the full habit, not less.
Fears and worries act like playground bullies — they want to ambush you. But when you deliberately seek them out and choose the time of engagement, they lose their power. The volitional act of starting the fight on your own terms is one of CBT's most underappreciated insights.
Most downtime defaults are things you regret immediately after — phone scrolling, binge TV. 'Glad you did it' activities meet the same need for rest but leave you feeling like you spent your time well. The switch from a bad screen to a documentary, a book, or a walk costs almost no extra effort but compounds into identity over time.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.